Why Fear Free starts before the exam room

A new VETgirl podcast is reinforcing a message that's been gaining traction across companion animal practice: sedation isn't surrender, and Fear Free care begins well before a patient steps into the hospital. In the episode, Dr. Erica Thiel, director of clinical excellence at IndyVets, talks with Dr. Jennifer Merlo, vice president of veterinary affairs at Fear Free, about pre-visit sedation, emotional safety, and why thoughtful handling and pharmacologic support can improve care for both patients and veterinary teams. The framing matters because it pushes sedation away from the old "last resort" mindset and toward routine, individualized planning for fear, anxiety, and stress. (vetgirlontherun.com)

That conversation fits squarely within Fear Free's broader mission. Fear Free describes itself as a science-based, behavior-led approach designed to prevent and reduce fear, anxiety, and stress in pets, and its certification and practice standards explicitly include knowledge of pre-visit pharmaceuticals and other environmental and handling strategies. In other words, the podcast isn't introducing a new doctrine so much as translating established Fear Free principles into a more direct message for everyday practice: emotional wellbeing is part of medical care. (fearfreepets.com)

The clinical backdrop is well established, especially in feline medicine. AAFP guidance says pharmacotherapy can significantly lessen a cat's distress, but shouldn't replace a cat-friendly environment and gentle handling. The same guidance notes that sedation or anesthesia with analgesia may be appropriate to prevent injury and worsening fear in some cats, and that anxiolytics should be considered for future appointments. Fear Free educational materials make a similar point for dogs and cats, recommending individualized pre-visit plans, starting at the lower end of dose ranges, and using a "practice" dose before the appointment to assess response. They also note that use of trazodone as a pre-visit pharmaceutical doesn't preclude later injectable sedation or anesthesia when needed. (catvets.com)

The evidence base behind those recommendations continues to grow. In cats, a placebo-controlled JAVMA study found that a single preappointment dose of gabapentin lowered owner-assessed stress during transportation and examination and improved veterinarian-assessed compliance. More recent work has also reported that gabapentin reduced stress in clinically normal cats during veterinary visits, while a placebo-controlled study in dogs found that a single oral dose of gabapentin alleviated stress during a veterinary visit. Taken together, those findings support what many clinicians already see in practice: lowering arousal before arrival can make the visit safer, more efficient, and more diagnostically productive. (pubmed.ncbi.nlm.nih.gov)

Industry messaging has also shifted toward normalizing that approach with pet parents. Fear Free client-facing materials say a successful visit may include anti-anxiety or calming medications before travel, and older educational pieces explicitly advise teams to explain that these medications aren't meant to simply "drug" the patient, but to reduce fear, anxiety, and stress that can interfere with treatment. That communication piece is likely one reason the VETgirl episode matters: it gives veterinary professionals language to reframe sedation as preventive care, rather than as an embarrassing escalation. (fearfreepets.com)

Why it matters: For veterinary professionals, this is less about branding than about operations and outcomes. Patients that arrive less distressed are often easier and safer to examine, sample, image, and treat. That can reduce staff injury risk, improve quality of diagnostics, and help avoid the cycle in which one traumatic visit makes the next one harder. It may also strengthen client relationships when pet parents understand that emotional safety is being treated as part of the standard of care. The caveat, reflected in both Fear Free and AAFP materials, is that pharmacologic support works best as one part of a broader plan that includes history-taking, environmental modification, respectful handling, analgesia when indicated, and documentation of what worked for the next visit. (catvets.com)

One practical nuance for clinicians is that pre-visit medication can affect some in-hospital measurements. For example, a 2024 study reported that gabapentin lowered blood pressure readings in cats with and without chronic kidney disease, which is useful context when practices are building protocols for anxious feline patients who also need hypertension workups. That's not an argument against pre-visit pharmaceuticals, but a reminder that protocol design, timing, and interpretation still require clinical judgment. (pubmed.ncbi.nlm.nih.gov)

What to watch: The next step is likely more protocolization, not less, with practices building clearer triage questions, trial-dose instructions, and patient-specific visit plans that combine handling, environment, analgesia, and pre-visit medication into one repeatable Fear Free workflow. (fearfreepets.com)